Oncology and Hematology
Episodes 161-176 of 304
Kami Maddocks, MD
Matthew J. Matasar, MD
Paul P. Doghramji, MD, FAAFP
Rami Komrokji, MD
Allan Platt, PA-C, MMSc
- CME/CE Broadcast Replay
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
1.00 creditNeeraj Agarwal, MD, FASCO
- Project Oncology®
Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes
Charles Turck, PharmD, BCPS, BCCCP
Adam H. Buchanan, MS, MPH
Charles Turck, PharmD, BCPS, BCCCP
Erin Kopp, ACNP-BC
- Project Oncology®
Addressing Unmet Needs in Chronic GVHD Care with Preventative & Telemedicine Strategies
Arpita Gandhi, MD, MS
- Project Oncology®
Early Intervention Strategies for Chronic GVHD: How to Take a Proactive & Multidisciplinary Approach
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Zach DeFilipp, MD
Charles Turck, PharmD, BCPS, BCCCP
Doris M. Ponce, MD, MS
Charles Turck, PharmD, BCPS, BCCCP
Doris M. Ponce, MD, MS
Annie Im, MD
Charles Turck, PharmD, BCPS, BCCCP
Ned Waller, MD, PhD, FACP
George Chen, MD
- Project Oncology®
Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Based on Mutation, Methylation, Aneuploidy, & Protein Biomarkers
Charles Turck, PharmD, BCPS, BCCCP
Frank Diehl, PhD
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
- MinuteCE®
Metastatic Melanoma: Solving Clinical Dilemmas in Frontline ICI Treatment
0.50 credits 3 episodesJason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
Jason J. Luke, MD, FACP
Elizabeth Buchbinder, MD
- Project Oncology®
Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden
Charles Turck, PharmD, BCPS, BCCCP
Betsy O'Donnell, MD